Biochemical Analysis of Caur SOD4, a Potential Therapeutic Target for the Emerging Fungal Pathogen Candida auris

ACS Infect Dis. 2022 Mar 11;8(3):584-595. doi: 10.1021/acsinfecdis.1c00590. Epub 2022 Feb 18.

Abstract

Candida auris is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat C. auris. Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in C. auris. We show here that C. auris secretes an enzymatically active Cu-only SOD (CaurSOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls, CaurSOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide. CaurSOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover, CaurSOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight CaurSOD4 as a potential antifungal target worthy of consideration.

Keywords: Candida auris; copper; fungi; metalloenzyme; superoxide; superoxide dismutase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents* / pharmacology
  • Candida auris* / drug effects
  • Candida auris* / enzymology
  • Candida auris* / metabolism
  • Candida auris* / pathogenicity
  • Copper / metabolism
  • Drug Resistance, Multiple, Fungal* / drug effects
  • Drug Resistance, Multiple, Fungal* / physiology
  • Mammals / metabolism
  • Superoxide Dismutase* / metabolism
  • Virulence / physiology
  • Zinc / metabolism

Substances

  • Antifungal Agents
  • Copper
  • Superoxide Dismutase
  • Zinc